Paxillin Polyclonal antibody

Paxillin Polyclonal Antibody for WB, IF, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, Canine, mouse

Applications

WB, IF, IHC, ELISA

Conjugate

Unconjugated

Cat no : 22172-1-AP

Synonyms

paxillin, PXN



Tested Applications

Positive WB detected inRAW 264.7 cells
Positive IHC detected inhuman breast cancer tissue, human stomach cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inMDCK cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)/ICCIF/ICC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 22172-1-AP is Paxillin Fusion Protein expressed in E. coli.

Tested Reactivity human, Canine, mouse
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Paxillin fusion protein Ag17702
Full Name paxillin
Calculated Molecular Weight 591 aa, 65 kDa
GenBank Accession NumberBC136787
Gene Symbol Paxillin
Gene ID (NCBI) 5829
RRIDAB_2879016
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for Paxillin antibody 22172-1-APDownload protocol
IHC protocol for Paxillin antibody 22172-1-APDownload protocol
IF protocol for Paxillin antibody 22172-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB,IHC

Oncogene

KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer.

Authors - H Zhang
humanWB

Sci Rep

A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways.

Authors - Ya Liu
humanWB

Sci Rep

Interferon-inducible protein, IFIX, has tumor-suppressive effects in oral squamous cell carcinoma

Authors - ShanWang
humanWB

Int J Oncol

Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.

Authors - Lupeng Wang
humanWB

Cell Death Discov

A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.

Authors - Pengyun Li
humanWB

Cell Signal

Activated CRH receptors inhibit autophagy by repressing conversion of LC3BI to LC3BII.

Authors - Lai Jin